Yield10 Bioscience Achieves Key Milestones in Early Development Program in Corn to Evaluate Novel Traits
The Company’s corn program began in early 2019, centered around the successful deployment of novel traits discovered by Yield10 into corn by a major third-party agriculture company partner. With this phase of the program complete, Yield10 recently contracted an additional third-party agriculture company to create homozygous and hybrid corn lines, bulk-up seed, and conduct field testing of the novel traits in corn to evaluate the impact on seed yield.
“Yield10’s corn development program continues to progress on schedule, benefiting from access to critical industry expertise and resources that will be crucial to the evaluation of our novel traits in this high value crop,” said
“The completed deployment of our traits in corn and the start of the next phase of development which will include field tests, are key milestones for Yield10 as it firmly places us further along the path toward licensing and commercialization of our novel yield traits in this important crop,” said
The yield traits in the corn development program include C3003, C3004, and C3011, as well as the transcription factors C4001, C4002, and C4003.
Corn is planted on approximately 90 million acres and is the highest value crop in
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, statements regarding the Company's intentions with regard to achieving the research objectives in the corn program, including its ability to produce new varieties of corn that are higher yielding, continuing to generate key proof points in crops of high commercial interest, the potential impact of results in the corn program on prospects for commercial partnerships and licensing opportunities, the potential impact of an improvement in seed yield in corn, and the timing for completion of the key steps in the early development program in corn, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in
Investor Relations Contact:
Managing Director, CORE IR
FischTank Marketing and PR
Source: Yield10 Bioscience, Inc.